Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6
Clinical Lymphoma Myeloma and Leukemia · 2026-05 · 26 (5) · 317-327.e10
DOI: 10.1016/j.clml.2026.02.006 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-05. Verfasst von David Andorsky und 22 weiteren Autor:innen. Beteiligte Einrichtung: Sarah Cannon Research Institute at Rocky Mountain Cancer Centers, Boulder, CO. Electronic address: David.Andorsky@usoncology.com. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Antibodies, Bispecific, Neoplasm Recurrence, Local. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AbbVie Inc, Genmab.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sarah Cannon Research Institute at Rocky Mountain Cancer Centers, Boulder, CO. Electronic address: David.Andorsky@usoncology.com.
- Hospital Auxilio Mutuo, San Juan, PR.
- Department of Hematology and Oncology, Atrium Wake Forest Baptist Health, Winston-Salem, NC.
- Department of Hematology and Oncology, Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL.
- Department of Medicine, Section of Hematology and Medical Oncology, OU Health Stephenson Cancer Center, Oklahoma City, OK.
- Department of Medicine, Division of Hematology and Oncology, Penn State Cancer Institute, Hershey, PA.
Förderung
- AbbVie Inc
- Genmab
Zitieren
APA
Andorsky, D., Lopez, A. T., Vaidya, R., Madueno, F. V., Ibrahimi, S., Naik, S., Gandhi, M., Haydu, J. E., Lash, B., Fesler, M., Hrom, J., Lee, E. H., Sundaram, S., Conte, K., Osei-Bonsu, K., Doerr, T., Bai, Y., Dixit, N., Eskelund, C. W., …, & Sharman, J. P. (2026). Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6. Clinical Lymphoma Myeloma and Leukemia, 26(5), 317-327.e10. https://doi.org/10.1016/j.clml.2026.02.006
Vancouver
Andorsky D, Lopez AT, Vaidya R, Madueno FV, Ibrahimi S, Naik S, et al. Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6. Clinical Lymphoma Myeloma and Leukemia. 2026;26(5):317-327.e10. doi:10.1016/j.clml.2026.02.006
BibTeX
@article{Andorsky2026,
author = {Andorsky, David and Lopez, Adelba Torres and Vaidya, Rakhee and Madueno, Fernando Vargas and Ibrahimi, Sami and Naik, Seema and Gandhi, Mitul and Haydu, Julie Erika and Lash, Bradley and Fesler, Mark and Hrom, John and Lee, Eric H and Sundaram, Suchitra and Conte, Kristin and Osei-Bonsu, Kojo and Doerr, Thomas and Bai, Yang and Dixit, Neha and Eskelund, Christian W and Boardman, Alexander P and Boccia, Ralph and Lee, Christina Y and Sharman, Jeff P},
title = {Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2026},
volume = {26},
number = {5},
pages = {317--327.e10},
doi = {10.1016/j.clml.2026.02.006}
}
EUVIMED